Clinical Trials on Multiple Primary Cancers in United Kingdom
Total 45660 results
-
University of OxfordMedical Research CouncilCompletedMultiple System Atrophy | Gait Disorders, Neurologic | Bladder, Neurogenic | Autonomic Failure | Postural HypotensionUnited Kingdom
-
University of GlasgowCompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
University College, LondonUniversity of Oxford; Newcastle University; University of Cambridge; University... and other collaboratorsRecruitingCorticobasal Degeneration | Multiple System Atrophy (MSA) | Progressive Supranuclear Palsy (PSP)United Kingdom
-
King's College LondonRecruitingSurgery | Patient Satisfaction | Patient Preference | Muscle Invasive Bladder Cancer | Sexual WellbeingUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cancer Research UK; National Institute for...Completed
-
Bristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterWithdrawnMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
University of LeicesterRecruitingCoronary Artery Disease | Cardiac Valve Disease | Organ Failure, MultipleUnited Kingdom
-
University of LeicesterRecruitingCoronary Artery Disease | Cardiac Valve Disease | Organ Failure, MultipleUnited Kingdom
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownOvarian Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
SanofiCompletedMultiple Sclerosis Healthy SubjectsUnited Kingdom
-
Swansea UniversityAbertawe Bro Morgannwg University Health BoardCompletedBladder CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UKRecruitingGynaecological CancersUnited Kingdom
-
Imperial College Healthcare NHS TrustCompletedPrimary Ciliary DyskinesiaUnited Kingdom
-
University College, LondonCancer Research UKRecruitingMultiple Myeloma | MGUS | Smouldering MyelomaUnited Kingdom
-
Imperial College LondonRecruiting
-
M.D. Anderson Cancer CenterActive, not recruitingMalignant Neoplasms of Independent (Primary) Multiple Sites | Benign NeoplasmsUnited States
-
University of EdinburghNHS LothianCompletedPancreatic Cancer | Gastrointestinal Cancer | Bile Duct Neoplasms | Cancer of Unknown Primary SiteUnited Kingdom
-
Imperial College LondonCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Medical Research CouncilCompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
University of ExeterRecruiting
-
Cardiff UniversityNovartisUnknownTuberous SclerosisUnited Kingdom
-
University College, LondonUnknownMultiple System AtrophyUnited Kingdom
-
Imperial College LondonImperial College Healthcare NHS TrustCompleted
-
Riverside Haematology GroupUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
The Christie NHS Foundation TrustHoffmann-La Roche; Concr; Durham UniversityActive, not recruitingCancer of Unknown Primary SiteUnited Kingdom
-
The Christie NHS Foundation TrustCompletedBreast Cancer | Multiple Myeloma | Gastrointestinal Cancer | Gynaecological CancerUnited Kingdom
-
University College London HospitalsCompleted
-
Imperial College London4D pharma plcActive, not recruitingMelanoma | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Renal Cancer | Urethral Cancer | Uterine CancerUnited Kingdom
-
University College, LondonKing's College London; Imperial College London; Medical Research Council; Cancer...Completed
-
Origin SciencesQueen Mary University of London; Royal Devon and Exeter NHS Foundation TrustRecruitingPancreatic Cancer | Gastric Adenocarcinoma | Non Small Cell Lung Cancer | Bladder Cancer | Gall Bladder CancerUnited Kingdom
-
East and North Hertfordshire NHS TrustKDx Diagnostics Inc.Recruiting
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomUnknown
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited Kingdom
-
Canbex Therapeutics LtdCompletedSpasticity in People With Multiple SclerosisUnited Kingdom
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Royal Marsden NHS Foundation TrustUnknownSarcoma | Cervical Cancer | Testicular Germ Cell Tumor | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Radiation Toxicity | Vaginal Cancer | Gastrointestinal Complications | Long-term Effects Secondary to Cancer Therapy in AdultsUnited Kingdom
-
University of SouthamptonAssistance Publique - Hôpitaux de Paris; Hacettepe University; Universitaire... and other collaboratorsUnknownPrimary Ciliary DyskinesiaUnited Kingdom
-
University of LeedsKaryopharm Therapeutics Inc; Myeloma UKWithdrawnMyeloma MultipleUnited Kingdom
-
Avacta Life Sciences LtdRecruitingSoft Tissue Sarcoma | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Biliary Tract Cancer | Oesophageal Cancer | Cancer of Unknown Primary SiteUnited States, United Kingdom
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
Merck KGaA, Darmstadt, GermanyMerck Serono Limited, UKCompletedRelapsing Multiple SclerosisUnited Kingdom
-
Institute of Cancer Research, United KingdomProstate Cancer UKRecruitingCastration-resistant Prostate Cancer | Metastatic Prostate CancerUnited Kingdom
-
Royal Marsden NHS Foundation TrustUnknownAdvanced Gastrointestinal CancersUnited Kingdom
-
Medical Research CouncilUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Barts & The London NHS TrustTerminatedCastrate Resistant Prostate CancerUnited Kingdom
-
University of OxfordVaccitech (UK) LimitedUnknownCastration-resistant Prostate Cancer | Intermediate Risk Prostate CancerUnited Kingdom